previous compound ID: 245 next compound
InChIKey: BKXVVCILCIUCLG-UHFFFAOYSA-N
SMILES: C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "J Goepp" "JW Hanrahan" "D Rotin" "R Robert" "J Liao" "GW Carlile" "B Kus" "SD Macknight" "E Matthes"

chemical graph of compound 245





CID is 54900
synonyms found at PubChem are:
RALOXIFENE HYDROCHLORIDE, 82640-04-8, Raloxifene Hcl, Evista, Keoxifene hydrochloride, (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride, Raloxifene (hydrochloride), LY 156758, UNII-4F86W47BR6, CHEBI:50740, Evista (Raloxifene Hydrochloride), 4F86W47BR6, 6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride, C28H28ClNO4S, DSSTox_CID_14181, DSSTox_RID_79119, DSSTox_GSID_34181, [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride, 2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol hydrochloride, LY-156758, 2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol hydrochloride, Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride, SMR000058508, NCGC00015889-05, CAS-82640-04-8, Loxifen, Optruma, SR-01000076102, Keoxifene HCl, CDT-Raloxifene, Raloxifene hydrochloride [USAN], [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride, Evista (TN), Prestwick_1035, Raloxifene hydrochloride [USAN:USP], Methanone, hydrochloride, AC1L1HY9, AC1Q3F5K, C28H27NO4S.HCl, Study Drug, raloxifene HCI, CHEMBL1116, SCHEMBL19077, MLS000859902, MLS001332533, MLS001332534, MLS002222293, Raloxifene hydrochloride, solid, Evista, Raloxifene hydrochloride, DTXSID1034181, CTK7J9865, KS-00000JPS, LY-139481 HCl, BKXVVCILCIUCLG-UHFFFAOYSA-N, HMS1570N05, Pharmakon1600-01505622, 84449-90-1 (Parent), BCP05713, Raloxifene hydrochloride (JAN/USP), Tox21_110255, Tox21_302369, Tox21_501051, ANW-54600, HY-13738A, MFCD01938233, NSC706725, NSC759285, s1227, AKOS008131940, Tox21_110255_1, AC-8390, AN-8061, CCG-213497, CS-1775, DS-2162, KS-1102, LP01051, MCULE-7336063262, NC00665, NSC-706725, NSC-759285, RP17875, VA11647, NCGC00015889-03, NCGC00015889-11, NCGC00092353-01, NCGC00092353-03, NCGC00094334-01, NCGC00094334-02, NCGC00255153-01, NCGC00261736-01, 4CA-1076, BC209548, CPD000058508, LS-91271, LY156758, SAM002548975, SC-20043, AB0020647, TC-063566, EU-0101051, FT-0630912, R0109, ST24020666, V1611, EN300-52517, D02217, J90021, M-8965, R 1402, 68523-EP2270008A1, 68523-EP2292617A1, 68523-EP2298768A1, 68523-EP2308855A1, 640R048, I06-1061, I14-1208, Q-201656, SR-01000076102-2, SR-01000076102-9, Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard, Raloxifene Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Raloxifene hydrochloride, United States Pharmacopeia (USP) Reference Standard, [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride, [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride, [6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride, [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride, [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Hydrochloride, [6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone hydrochloride, [6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride, [6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride, [6-hydroxy-2[4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride, 1-[2-(4-{[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]carbonyl}phenoxy)ethyl]piperidinium chloride, 6-hydroxy-2-(4-hydroxyphenyl)-3-[ 4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene, hydrochloride, 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]-thiophene hydrochloride, 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]thiophene hydrochloride, 6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl methanone hydrochloride, 6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl ketone hydrochloride, Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl) (4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride, Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-,hydrochloride (1:1), Raloxifene hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard, MLS001304731, HMS2233M16, HMS3372E10, AKOS015960340, SMR000752510, AKOS026750144, SCHEMBL19287207